Companion Animal Postoperative Pain Management Therapeutics Market Size

Companion Animal Postoperative Pain Management Therapeutics Market Size

Companion Animal Postoperative Pain Management Therapeutics Market size accounted for USD 133.5 million in 2023 and is expected to showcase growth at a CAGR of 6.5% from 2024 to 2032. The growth of the market is driven by the increasing prevalence of surgical procedures in companion animals.  

To get key market trends

  Download Free Sample

As pet ownership rises and veterinary care advances, there is a growing demand for effective pain management solutions post-surgery. For instance, according to the American Pet Products Association (APPA), pet ownership in the U.S. has reached 85 million, with millions of pets undergoing surgeries annually. This growing number of surgical interventions needs effective pain management, highlighting the importance of therapeutics in ensuring animal welfare and recovery.
 

Moreover, rising awareness among pet owners about the importance of postoperative pain management is a significant driver of market growth. With an increasing understanding of the ethical considerations and benefits of pain relief, pet owners are more inclined to seek veterinary care that includes comprehensive pain management plans. Furthermore, the regulatory landscape for veterinary medicines has become more favorable, encouraging the development and approval of new pain management products. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have streamlined approval processes and provided clear guidelines for veterinary therapeutics, facilitating market entry for new products.
 

The companion animal postoperative pain management therapeutics market refers to the segment of the veterinary pharmaceutical industry that focuses on the development, manufacturing, and distribution of medications and therapies specifically designed to manage pain in companion animals following surgical procedures.